Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 16CNS 3Thoracic 1Lymphoid 1

Conditions

Lymphoma 5Lymphoma, Follicular 2Oligodendroglioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 7Nivolumab 3Drug Therapy 3Biopsy, Fine-Needle 3epacadostat 2Thiotepa 2Nonlinear Optical Microscopy 2Ipilimumab 2Gemcitabine 2Filgrastim 2Cytological Techniques 2Cyclophosphamide 2Blood Specimen Collection 2vocimagene amiretrorepvec 1tanespimycin 1spartalizumab 1motexafin gadolinium 1fludarabine 1entrectinib 1belinostat 1atezolizumab 1alectinib 1aldesleukin 1Valganciclovir 1Topotecan 1Tomography, Emission-Computed 1Tissue Banks 1Sirolimus 1SUB1 protein, human 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Chemotherapy, Adjuvant × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡